Data from a prospective mix-methods operational feasibility study aiming to assess the operational feasibility and impact, safety, acceptability and cost of a revised treatment algorithm for P.vivax malaria that includes point of care semi-quantitative G6PD testing and radical cure treatment with primaquine (PQ) or tafenoquine (TQ). This study had three stages: 1) a formative assessment, 2) an introduction of the revised algorithm in 5 health facilities and 3) an expansion of the revised algorithm to additional facilities, including health centers and health posts.